WHO (N)SAID?

The WHO initially recommended against ibuprofen use in patients with COVID-19 based on early reports of potential harm. This large cohort study found no association between NSAID use and adverse outcomes among patients diagnosed with COVID-19. | Lund, PLOS Medicine 2020